Subscribe Sign In Register

taub.png

Stephen Taub

Latest articles
Art_ThirdPointBullish_1207.jpg
Premium
How Third Point Fared After Increasing Bets on Stocks
Stephen Taub
December 7, 2023
carmot-taub-25.jpg
Premium
Prominent Hedge Funds Stand to Benefit From Biopharma’s Change of Plans
Stephen Taub
December 6, 2023
art_biopharmup_1205.jpg
Premium
Biopharma Bonanza
Stephen Taub
December 5, 2023
Art_GreenlinghtDown_1204.jpg
Premium
Greenlight Suffers a Setback in November
Stephen Taub
December 4, 2023
Art_Soleus_1130 (1).jpg
Premium
Soleus Goes Activist
Stephen Taub
November 30, 2023
Art_BiophmarmaIPO_1129.jpg
Premium
Hedge Funds Eye Next Biopharma IPO
Stephen Taub
November 29, 2023
Art_Deerfield_1128.jpg
Premium
Deerfield Launches New VC Fund
Stephen Taub
November 28, 2023
Art_AMZMIcrogoinUP_1127.jpg
Premium
Narrow Trade
Stephen Taub
November 27, 2023
Art_instacart_1122.jpg
Premium
Hedgies Shop for Instacart
Stephen Taub
November 22, 2023
Art_Druckenmiller_1121.jpg
Premium
Stan Druckenmiller Condolidates His Stock Holdings
Stephen Taub
November 21, 2023
Art-Bullishthridpoint_1120.jpg
Premium
Third Point’s Credit Bet
Stephen Taub
November 20, 2023
Art_LonePine_1116.jpg
Premium
A Look Into Tiger Descendants’ Activity in the Third-Quarter
Stephen Taub
November 16, 2023
art_TCI_1115.jpg
Premium
TCI, Whale Rock and Other Hedge Funds Made Major Moves in the Third-Quarter
Stephen Taub
November 15, 2023
Art_Bridgewatertwofundss_1113.jpg
Premium
Bridgewater Launches Two Funds
Stephen Taub
November 13, 2023
Art_Greenlight_0906.jpg
Premium
Greenlight Sharply Cuts Its Market Bet
Stephen Taub
November 9, 2023
Art_Icahn_1107.jpg
Premium
Icahn’s Investment Fund Plunges Deeper Into the Red
Stephen Taub
November 8, 2023
Art_ThirdPoint_1106.jpg
Premium
Third Point Slashes Market Exposure
Stephen Taub
November 7, 2023
Art_Citadel_1106.jpg
Premium
Citadel Continues to Set the Pace
Stephen Taub
November 6, 2023